PharmaEssentia (TPE:6446) ROE % Adjusted to Book Value: 3.50% (As of Dec. 2025)


TPE:6446 PharmaEssentia Corp TPE:6446
82 GF Score
Price NT$1,445.00
GF Value NT$1,352.07
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is PharmaEssentia ROE % Adjusted to Book Value?

PharmaEssentia TPE:6446 +3.58% 82 ROE % Adjusted to Book Value is 3.50% as of Dec. 2025. GuruFocus rates TPE:6446 with a GF Score™ of 82/100 and a GF Value™ of NT$1,352.07 (Fairly Valued). The stock has 6 warning signs investors should review.

PharmaEssentia's ROE % for the quarter that ended in Dec. 2025 was 19.13%. PharmaEssentia's PB Ratio for the quarter that ended in Dec. 2025 was 5.46. PharmaEssentia's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 3.50%.

PharmaEssentia ROE % Adjusted to Book Value Related Terms

PharmaEssentia ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia ROE % Adjusted to Book Value Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.66 -1.42 -0.72 1.60 3.11

PharmaEssentia Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.56 3.02 1.80 3.16 3.50

TPE:6446 vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaEssentia ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's ROE % Adjusted to Book Value falls into.


TPE:6446
82GF Score
PharmaEssentia Corp TPE:6446
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia ROE % Adjusted to Book Value Calculation

PharmaEssentia's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=16.97% / 5.46
=3.11%

PharmaEssentia's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=19.13% / 5.46
=3.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 3.50% mean?
PharmaEssentia (TPE:6446) has a ROE % Adjusted to Book Value of 3.50% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's ROE % Adjusted to Book Value too high?
PharmaEssentia's current ROE % Adjusted to Book Value is 3.50%. Overall, PharmaEssentia has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's ROE % Adjusted to Book Value compare to ZTS and UTHR?
PharmaEssentia's ROE % Adjusted to Book Value of 3.50% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current ROE % Adjusted to Book Value is 3.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
Based on GuruFocus' analysis, PharmaEssentia (TPE:6446) is currently considered Fairly Valued. The stock's GF Value™ is NT$1,352.07, compared to a current price of NT$1,445.00 — trading 6.9% above its estimated fair value. The current ROE % Adjusted to Book Value is 3.50%. PharmaEssentia's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PharmaEssentia (TPE:6446), the current ROE % Adjusted to Book Value is 3.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (TPE:6446) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of NT$1,445.00 is trading 6.9% above its estimated GF Value™ of NT$1,352.07. GuruFocus considers PharmaEssentia to be Fairly Valued.

Key valuation signals for TPE:6446:

  • ROE % Adjusted to Book Value: 3.50%
  • GF Value™: NT$1,352.07 vs. price of NT$1,445.00 (6.9% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEssentia Business Description

Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score

Get the complete analysis for TPE:6446

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,445.00
Price
NT$1,352.07
GF Value